Carlsmed, Inc. Net Fee Amt
Carlsmed, Inc. (CARL) had Net Fee Amt of $34.52 thousand as of 2026-08-07, per its S-3 filed 2026-08-14.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-14
- 2026-08-07: Net Fee Amt $34.52K.
| Period end | Net Fee Amt |
|---|---|
| 2026-08-07 | $34.52K S-3 · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |